Los Angeles Biotech News

2024 VISION Summit: SprintRay to Unveil Cutting Edge BioMaterial Innovation Lab

2024 VISION Summit Announcements Include Next-Generation Resin Portfolio and Product Roadmap LOS ANGELES, Jan. 31, 2024 /PRNewswire/ — SprintRay proudly announces its 2024 VISION Summit, a groundbreaking event highlighting the company’s significant strides in shaping […]

Los Angeles Biotech News

San Diego-Based Path-Now App Improving Life for Those with Intellectual and Developmental Disabilities

Free App is Earning Rave Reviews from Satisfied IDD Community LOS ANGELES, Jan. 30, 2024 /PRNewswire-PRWeb/ — The San Diego-based Path-Now app is changing the way individuals within the intellectual and developmental disability (IDD) community […]

Los Angeles Biotech News

PAPA ROACH CONTINUES SUPPORTING MENTAL HEALTH AND SUICIDE PREVENTION AWARENESS WITH RELEASE OF “SCARS FEAT. CHRIS DAUGHTRY (LIVE)”

Papa Roach Pledges Donation to the American Foundation for Suicide Prevention and Ongoing Support of the Organization’s Talk Away the Dark Public Service Campaign LOS ANGELES, Jan. 30, 2024 /PRNewswire/ — After surprising and captivating […]

Los Angeles Biotech News

AcuraStem Secures $7 Million in Funding Support from NIH and DOD to Accelerate Therapies for ALS and FTD

AcuraStem Leverages iNeuroRx® Platform to Drive Innovative SYF2 and UNC13A Treatments Forward Toward Clinical Trials PASADENA, Calif., Jan. 30, 2024 /PRNewswire/ — AcuraStem, a patient-based biotechnology company advancing treatments for amyotrophic lateral sclerosis (ALS),… Click […]

Los Angeles Biotech News

The academic-entrepreneur model built companies and minted millionaires. What happens when one of its earliest advocates quits?  

CAMBRIDGE, Mass. — For years in a small handful of US research and venture capital hot spots, a careful balance has brought prestige and wealth to universities, academics and investors. From inside their labs, professors […]

No Picture
Los Angeles Biotech News

Sound Pharma to present positive interim data from its Phase 2b Cystic Fibrosis STOP Ototoxicity Trial

SEATTLE, Jan. 30, 2024 /PRNewswire/ — Sound Pharmaceuticals (SPI) will present the Phase 2b STOP Ototoxicity data that was selected for podium presentation at the Association for Research in Otolaryngology (ARO) Midwinter Meeting in Anaheim, […]

Los Angeles Biotech News

Kite Receives U.S. FDA Approval of Manufacturing Process Change Resulting in Reduced Median Turnaround Time for Yescarta® CAR T-cell Therapy

SANTA MONICA, Calif.–(BUSINESS WIRE)–Kite, a Gilead Company (Nasdaq: GILD), today announced that the U.S. Food and Drug Administration (FDA) has approved a manufacturing process change resulting in a shorter manufacturing time for Yescarta® (axicabtagene ciloleucel). […]